Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis: A quantitative T1 relaxation time mapping approach

Journal of Neurology

Volumn 250, Issue 3, 2003, Pages 307-315

  Vaithianathar, Lalitha ^a   Tench, Chris R ^a   Morgan, Paul S ^a   Constantinescu, Cris S ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Cervical cord; Magnetic Resonance Imaging; Multiple sclerosis; Normal appearing white matter; T1 relaxation time

Indexed keywords

ADULT; ARTICLE; CERVICAL SPINAL CORD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISABILITY; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PRIORITY JOURNAL; RELAPSING REMITTING MULTIPLE SCLEROSIS; SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS; TISSUE INJURY; WHITE MATTER;

ADULT; CERVICAL VERTEBRAE; DISABILITY EVALUATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; REPRODUCIBILITY OF RESULTS; SPINAL CORD; TELENCEPHALON;

EID: 0037355862     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-003-1001-8     Document Type: Article

References (45)

1. Barnes D, McDonald WI, Johnson G, et al. (1987) Quantitative nuclear magnetic resonance imaging: characterisation of experimental cerebral oedema. J Neurol Neurosurg Psychiatry 50:125-133
2. Barnes D, Munro PM, Youl BD, et al. (1991) The longstanding MS lesion. A quantitative MRI and electron microscopic study. Brain 114:1271-1280
3. Bjartmar C, Kidd G, Mork S, et al. (2000) Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 48:893-901
4. Bjartmar C, Kinkel RP, Kidd G, et al. (2001) Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 57:1248-1252
5. Bjartmar C, Trapp BD (2001) Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol 14:271-278
6. 1 relaxation times, and metabolite concentrations. J Neurol Neurosurg Psychiatry 68:627-632
7. Ciccarelli O, Werring DJ, Wheeler-Kingshott CA, et al. (2001) Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 56:926-933
8. Cutter GR, Baier ML, Rudick RA, et al. (1999) Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 122 Part 5:871-882
9. Filippi M, Bozzali M, Horsfield MA, et al. (2000) A conventional and magnetization transfer MRI study of the cervical cord in patients with MS. Neurology 54:207-213
10. Ganter P, Prince C, Esiri MM (1999) Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol Appl Neurobiol 25:459-467
11. Griffin CM, Chard DT, Parker GJM, et al. (2002) The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis. J Neurol 249:193-199
12. 1 provide complementary information in MS NAWM, but not in lesions. Mult Scler 6:327-331
13. Guttmann L (1973) Spinal cord injuries: comprehensive management and research. Oxford: Blackwell Scientific
14. Haacke ME, Brown RW, Thompson MR, et al. (1999) Magnetic Resonance Imaging: Physical Principles and Sequence Design. Wiley-Liss
15. Hauser S, Dawson D, Lehrich J, et al. (1983) Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med 308:173-180
16. Ikuta F, Zimmerman HM (1976) Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States. Neurology 26:26-28
17. 1 measurement using snapshot-FLASH MRI. J Magn Reson 127:65-72
18. Kameyama T, Hashizume Y, Ando T, et al. (1994) Morphometry of the normal cadaveric cervical spinal cord. Spine 19:2077-2081
19. Kapeller P, McLean MA, Griffin CM, et al. (2001) Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study. J Neurol 248:131-138
20. Kidd D, Thorpe JW, Thompson AJ, et al. (1993) Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 43:2632-2637
21. Kurtzke JF (1984) Disability rating scales in multiple sclerosis. Ann N Y Acad Sci 436:347-360
22. Lassmann H, Suchanek G, Ozawa K (1994) Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. Ann Neurol 36:S42-S46
23. Loevner LA, Grossman RI, Cohen JA, et al. (1995) Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 196:511-515
24. Losseff NA, Webb SL, O'Riordan JI, et al. (1996) Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 119:701-708
25. Lovas G, Szilagyi N, Majtenyi K, et al. (2000) Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 123 Part 2:308-317
26. Lycklama a Nijeholt GJ, Barkhof F, Scheltens P, et al. (1997) MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. AJNR Am J Neuroradiol 18:1041-1048
27. Lycklama a Nijeholt GJ, van Walderveen MA, Castelijns JA, et al. (1998) Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 121:687-697
28. Matthews PM, Arnold DL (2001) Magnetic resonance imaging of multiple sclerosis: new insights linking pathology to clinical evolution. Curr Opin Neurol 14:279-287
29. Naruse S, Horikawa Y, Tanaka C, et al. (1982) Proton nuclear magnetic resonance studies on brain edema. J Neurosurg 56:747-752
30. Poser CM, Paty DW, Scheinberg L, et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
31. nd edition. Cambridge University Press Cambridge
32. Rocca MA, Mastronardo G, Horsfield MA, et al. (1999) Comparison of three MR sequences for the detection of cervical cord lesions in patients with multiple sclerosis. AJNR. American Journal of Neuro radiology 20:1710-1716
33. Rovaris M, Bozzali M, Santuccio G, et al. (2000) Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis. J Neurol Neurosurg, and Psychiatry 69:723-727
34. Simon JH, Kinkel RP, Jacobs L, et al. (2000) A Wallerian degeneration pattern in patients at risk for MS. Neurology 54:1155-1160
35. nd edition. Brooks and Cole Publishing California
36. nd edition. The CV. Mosby Company St Louis, Missouri
37. Stevenson VL, Leary SM, Losseff NA, et al. (1998) Spinal cord atrophy and disability in MS: a longitudinal study. Neurology 51:234-238
38. Tartaglino LM, Friedman DP, Flanders AE, et al. (1995) Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 195:725-732
39. Thorpe JW, Kidd D, Moseley IF, et al. (1996) Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology 46:373-378
40. Tofts PS, du Boulay EP (1990) Towards quantitative measurements of relaxation times and other parameters in the brain. Neuroradiology 32:407-415
41. Trapp BD, Bo L, Mork S, et al. (1999) Pathogenesis of tissue injury in MS lesions. J Neuroimmunol 98:49-56
42. 1 relaxation time histograms and cerebral atrophy in multiple sclerosis. J Neurol Sci 197:45-50
43. van Waesberghe JH, Castelijns JA, Scheltens P, et al. (1997) Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions. Magn Reson Imaging 15:155-162
44. van Waesberghe JH, Kamphorst W, De Groot CJ, et al. (1999) Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46:747-754
45. 1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy. Ann Neurol 46:79-87